SGLT2 inhibitors shown (again) to deliver cardiovascular benefits…

Canadian researchers have added to the considerable raft of evidence in support of thee use of SGLT2 inhibitor drugs as a means to reduce cardiovascular events. In a large study the risk of cardiovascular events observed in subjects treated with sodium glucose...

Opioids remain prominently represented amongst medication incidents

An Australian study has examined opioid-related medication safety incidents there documented in all public hospitals in a single state of Australia , between 1 July 2017 and 30 June 2018. Opioids were implicated in 11.0% (857) of all medication‐related clinical...